Constantly presenting new possibilities for the
prevention and treatment of disease. Directive 2001/82/
EC, which both sets out standards for veterinary
medicinal products and outlines the authorisation
procedures, focuses on the established pharmaceutical
and immunological product types, and has no scope to
provide a framework for innovative products that fall
outside these categories. Anja Holm, independent
consultant at Central VetPharma Consultancy, and
Pascale Canning at Cyton Biosciences discuss how this
can often frustrate and confuse companies wishing to
market a product, and may be a block to useful
products becoming available to veterinarians, farmers,
and pet owners.

Comments are closed.